Navigation Links
ETEX Corporation to present at the 9th World Biomaterial Congress
Date:5/22/2012

CAMBRIDGE, Mass., May 22, 2012 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, today announced two presentations at the upcoming 9th World Biomaterial Congress, June 1-5, 2012 in Chengdu, China. ETEX will highlight their vertebral augmentation and cell carrier development programs.

Dr. Jerry Chang, Head of R&D of ETEX Corporation, will deliver an oral presentation entitled "Enhanced Calcium Phosphate Cements for Vertebral Augmentation" during Rapid Fire Session (R3), June 3rd 2012. Dr. Chang will highlight an injectable Calcium Phosphate scaffold with superior cancellous bone filling, hard setting, and cell mediated remodeling for bone regeneration in vertebral compression fracture repair applications.

ETEX Corporation scientific team will also showcase recent advancements in their Stem Cell Carrier program during the poster session (R1).  The presentation is entitled "Calcium Phosphate Combination Biomaterials as Human Mesenchymal Stem Cell (hMSC) Delivery Vehicles for Bone Repair." This marks ETEX's third presentation regarding their cell carrier platform in the last six months, following oral presentations at the 4th Annual World Congress of Regenerative Medicine & Stem Cell in Beijing, China, and the GTC 8th Stem Cell Summit in Boston, MA.

As a pioneer in implantable biomaterials and the delivery of orthobiologics, such as growth factors and cells, ETEX is excited to participate in this important event.

Brian Ennis, President and CEO of ETEX Corporation, comments: "ETEX is eager to highlight two important development platforms at the upcoming World Biomaterial Congress in Chengdu. The setting is particularly relevant as ETEX is collaborating with leading centers in China to further document the clinical efficacy of ETEX biomaterials. This collaborative initiative will result in additional clinical documentation and lead to commercialization of our leading orthobiologic platforms in the rapidly expanding Chinese orthopedic market."

About ETEX Corporation

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit www.etexcorp.com.


'/>"/>
SOURCE ETEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Corporation Announces New Credit Facility
2. Verenium Corporation To Announce First Quarter 2012 Financial Results
3. China Cord Blood Corporation Announces Completion of $65 Million Convertible Debt Financing with KKR
4. Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform
5. ETEX Corporation to Present at GTC Stem Cell Summit
6. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
7. Hamamatsu Corporation Announces Exclusive Distribution of Its NanoZoomer Whole-Slide Scanners
8. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
9. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
10. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
11. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Discovering new clues to natural treatments that could allow ... in our brains. And searching for keys to our immune systems by studying parasite-resistant ... the 2017 Edith and Peter O’Donnell Awards by The Academy of ...
(Date:12/6/2016)... ... December 06, 2016 , ... Clinical ... it has acquired the assets of Theorem Clinical Research - Clinical Supplies ... clinical trial drug packaging, labeling, storage, reconciliation, and distribution for pharmaceutical trials ...
(Date:12/6/2016)... 2016 Zimmer Biomet Holdings, Inc. (NYSE ... pricing terms of its previously-announced cash tender offers ... price (excluding accrued and unpaid interest to, but ... fees and expenses related to the Offers) (the ... in the table below (collectively, the "Notes"). The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) inhibited the direct neurotoxic effect of prion-like forms of Amyloid ...
Breaking Biology Technology:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... VILNIUS, Lithuania , Nov. 29, 2016 ... high-precision biometric identification and object recognition technologies, ... kit (SDK) for fingerprint recognition solutions that ... extract a fingerprint template using less than ... used in compact devices that have limited ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
Breaking Biology News(10 mins):